Table 2 Participant characteristics
Total Sample (n = 136) | Males (n = 89) | Females (n = 47) | |
|---|---|---|---|
Age (years) | 76 (Q1 71, Q3 79) | 75 (Q1 71, Q3 79) | 76 (Q1 72, Q3 79) |
MMSE (presurgical) | 26 (Q1 22, Q3 28, n = 83) | 26 (Q1 22, Q3 28, n = 47) | 25 (Q1 23, Q3 28, n = 26) |
TUG time (seconds, presurgical) | 17 (Q1 11.9, Q3 26.0, n = 83) | 16 (Q1 11.0, Q3 26.0, n = 47) | 18.3 (Q1 13.5, Q3 26.0, n = 26) |
Improved | 63 (75.9%, n = 83) | 45 (79%, n = 47) | 18 (69%, n = 26) |
VV | 141 mL (Q1 123, Q3 166) | 151 mL (Q1 128, Q3 179) | 133 mL (Q1 112, Q3 142) |
Aβ42 | 534 pg/mL (Q1 380, Q3 662) | 536 pg/mL (Q1 384, Q3 641) | 532 pg/mL (Q1 364, Q3 680) |
Tau | 216 pg/mL (Q1 163, Q3 300) | 208 pg/mL (Q1 163, Q3 274) | 220 pg/mL (Q1 160, Q3 331) |
p-tau | 31 pg/mL (Q1 23, Q3 40) | 30 pg/mL (Q1 23, Q3 38) | 33 pg/mL (Q1 24, Q3 45) |